Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1991007188) METHOD FOR REDUCING BLOOD CHOLESTEROL USING ARGININE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1991/007188 International Application No.: PCT/US1990/006119
Publication Date: 30.05.1991 International Filing Date: 23.10.1990
Chapter 2 Demand Filed: 05.06.1991
IPC:
A61K 31/195 (2006.01) ,A61K 38/04 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
195
having an amino group
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
04
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Applicants:
BARBUL, Adrian [US/US]; US
Inventors:
BARBUL, Adrian; US
Agent:
KADEN, Jeffrey, M.; Gottlieb, Rackman & Reisman 1430 Broadway New York, NY 10018, US
Priority Data:
440,58922.11.1989US
Title (EN) METHOD FOR REDUCING BLOOD CHOLESTEROL USING ARGININE
(FR) METHODE DE REDUCTION DU CHOLESTEROL SANGUIN A L'AIDE D'ARGININE
Abstract:
(EN) A method for reducing the level of cholesterol in the bloodstream of a human being is provided. The method comprises the administration to a human subject in vivo of an effective amount of an arginine or arginine derivative compound, or a related amino acid or derivative. Daily doses of these compounds have been found to significantly reduce blood cholesterol level.
(FR) Méthode destinée à faire baisser le taux de cholestérol dans le flux sanguin de l'être humain. Cette méthode consiste à administrer à un sujet humain in vivo une dose efficace d'arginine ou d'un dérivé d'arginine, un acide aminé apparenté ou un dérivé. On a constaté que des doses quotidiennes de ces substances réduisent considérablement le taux de cholestérol sanguin.
Designated States: AU, CA, JP
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0502007CA2069413AU1990067265